The nuclear localization signal is required for nuclear GPER translocation and function in breast Cancer-Associated Fibroblasts (CAFs)

Molecular and Cellular Endocrinology

Volumn 376, Issue 1-2, 2013, Pages 23-32

  Pupo, Marco ^a   Vivacqua, Adele ^a   Perrotta, Ida ^a   Pisano, Assunta ^a   Aquila, Saveria ^a   Abonante, Sergio ^b   Gasperi Campani, Anna ^c   Pezzi, Vincenzo ^a   Maggiolini, Marcello ^a  

^a UNIVERSITY OF CALABRIA   (Italy)

^b Regional Hospital   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Breast cancer; Cancer associated fibroblasts; Estrogen signaling; GPER; Nuclear localization signal

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; ESTROGEN; ESTROGEN RECEPTOR; G PROTEIN ESTROGEN RECEPTOR; KARYOPHERIN; PROTEIN C FOS; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER ASSOCIATED FIBROBLAST; CELL MIGRATION; CELL NUCLEUS; CONTROLLED STUDY; CTGF GENE; ESTROGEN ACTIVITY; FIBROBLAST; GENE TARGETING; HORMONE RECEPTOR TRANSLOCATION; HUMAN; HUMAN CELL; NUCLEAR LOCALIZATION SIGNAL; ONCOGENE C FOS; PRIORITY JOURNAL; PROTEIN FUNCTION; TUMOR MICROENVIRONMENT; UPREGULATION;

BREAST CANCER; CANCER-ASSOCIATED FIBROBLASTS; ESTROGEN SIGNALING; GPER; NUCLEAR LOCALIZATION SIGNAL;

ACTIVE TRANSPORT, CELL NUCLEUS; BREAST NEOPLASMS; CELL MOVEMENT; CELL NUCLEUS; CELL PROLIFERATION; CONNECTIVE TISSUE GROWTH FACTOR; ESTROGENS; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KARYOPHERINS; NUCLEAR LOCALIZATION SIGNALS; PRIMARY CELL CULTURE; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84879476386     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.05.023     Document Type: Article

References (91)

1. Aboussekhra A. Role of cancer-associated fibroblasts in breast cancer development and prognosis. Int. J. Dev. Biol. 2011, 55:841-849.
2. Albanito L., Lappano R., Madeo A., Chimento A., Prossnitz E.R., Cappello A.R., Dolce V., Abonante S., Pezzi V., Maggiolini M. G-protein-coupled receptor 30 and estrogen receptor-alpha are involved in the proliferative effects induced by atrazine in ovarian cancer cells. Environ. Health Perspect. 2008, 116:1648-1655.
3. Albanito L., Madeo A., Lappano R., Vivacqua A., Rago V., Carpino A., Oprea T.I., Prossnitz E.R., Musti A.M., Andò S., Maggiolini M. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17β-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res. 2007, 67:1859-1866.
4. Albanito L., Sisci D., Aquila S., Brunelli E., Vivacqua A., Madeo A., Lappano R., Pandey D.P., Picard D., Mauro L., Andò S., Maggiolini M. Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells. Endocrinology 2008, 149:3799-3808.
5. Bartella V., De Marco P., Malaguarnera R., Belfiore A., Maggiolini M. New advances on the functional cross-talk between insulin-like growth factor-I and estrogen signaling in cancer. Cell. Signal. 2012, 24:1515-1521.
6. Bedard J.E., Purnell J.D., Ware S.M. Nuclear import and export signals are essential for proper cellular trafficking and function of ZIC3. Hum. Mol. Genet. 2007, 16:187-198.
7. Bhattacharya M., Peri K., Ribeiro-da-Silva A., Almazan G., Shichi H., Hou X., Varma D.R., Chemtob S. Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope. J. Biol. Chem. 1999, 274:15719-15724.
8. Boivin B., Chevalier D., Villeneuve L.R., Rousseau E., Allen B.G. Functional endothelin receptors are present on nuclei in cardiac ventricular myocytes. J. Biol. Chem. 2003, 278:29153-29163.
9. Boivin B., Vaniotis G., Allen B.G., Hébert T.E. G protein-coupled receptors in and on the cell nucleus: a new signaling paradigm?. J. Recept. Signal. Trans. Res. 2008, 28:5-28.
10. Bologa C.G., Revankar C.M., Young S.M., Edwards B.S., Arterburn J.B., Kiselyov A.S., Parker M.A., Tkachenko S.E., Savchuck N.P., Sklar L.A., Oprea T.I., Prossnitz E.R. Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat. Chem. Biol. 2006, 2:207-212.
11. Canonaco M., Giusi G., Madeo A., Facciolo R.M., Lappano R., Canonaco A., Maggiolini M. A sexually dimorphic distribution pattern of the novel estrogen receptor G-protein-coupled receptor 30 in some brain areas of the hamster. J. Endocrinol. 2008, 196:131-138.
12. Chen R., Mukhin Y.V., Garnovskaya M.N., Thielen T.E., Iijima Y., Huang C., Raymond J.R., Ullian M.E., Paul R.V. A functional angiotensin II receptor-GFP fusion protein: evidence for agonist-dependent nuclear translocation. Am. J. Physiol. Renal Physiol. 2000, 279:F440-F448.
13. Chimento A., Sirianni R., Casaburi I., Ruggiero C., Maggiolini M., Andò S., Pezzi V. 17β-Estradiol activates GPER- and ESR1-dependent pathways inducing apoptosis in GC-2 cells, a mouse spermatocyte-derived cell line. Mol. Cell. Endocrinol. 2012, 355:49-59.
14. Chimento A., Sirianni R., Delalande C., Silandre D., Bois C., Andò S., Maggiolini M., Carreau S., Pezzi V. 17 Beta-estradiol activates rapid signaling pathways involved in rat pachytene spermatocytes apoptosis through GPR30 and ER alpha. Mol. Cell. Endocrinol. 2010, 320:136-144.
15. Chimento A., Sirianni R., Zolea F., Bois C., Delalande C., Andò S., Maggiolini M., Aquila S., Carreau S., Pezzi V. Gper and ESRs are expressed in rat round spermatids and mediate oestrogen-dependent rapid pathways modulating expression of cyclin B1 and Bax. Int. J. Androl. 2011, 34:420-429.
16. Christophe D., Christophe-Hobertus C., Pichon B. Nuclear targeting of proteins: how many different signals?. Cell. Signal. 2000, 5:337-341.
17. Cingolani G., Petosa C., Weis K., Müller C.W. Structure of importin-beta bound to the IBB domain of importin-alpha. Nature 1999, 399:221-229.
18. Cirri P., Chiarugi P. Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression. Cancer Metast. Rev. 2011, 31:195-208.
19. De Marco P., Bartella V., Vivacqua A., Lappano R., Santolla M.F., Morcavallo A., Pezzi V., Belfiore A., Maggiolini M. Insulin-like growth factor-I regulates GPER expression and function in cancer cells. Oncogene 2012, 10.1038/onc.2012.97.
20. Dennis M.K., Field A.S., Burai R., Ramesh C., Petrie W.K., Bologa C.G., Oprea T.I., Yamaguchi Y., Hayashi S., Sklar L.A., Hathaway H.J., Arterburn J.B., Prossnitz E.R. Identification of a GPER/GPR30 antagonist with improved estrogen receptor counterselectivity. J. Steroid Biochem. Mol. Biol. 2011, 127:358-366.
21. Dittmann K., Mayer C., Fehrenbacher B., Schaller M., Raju U., Milas L., Chen D.J., Kehlbach R., Rodemann H.P. Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase. J. Biol. Chem. 2005, 280:31182-31189.
22. Filardo E.J., Graeber C.T., Quinn J.A., Resnick M.B., Giri D., DeLellis R.A., Steinhoff M.M., Sabo E. Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression. Clin. Cancer Res. 2006, 12:6359-6366.
23. Filardo E.J., Quinn J.A., Bland K.I., Frackelton A.R. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 2000, 14:1649-1660.
24. Filardo E.J., Quinn J.A., Frackelton A.R., Bland K.I. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis. Mol. Endocrinol. 2002, 16:70-84.
25. Filardo E.J., Quinn J.A., Pang Y., Graeber C., Shaw S., Dong J., Thomas P. Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane. Endocrinology 2007, 148:3236-3245.
26. Filardo E.J., Thomas P. Minireview: G protein-coupled estrogen receptor-1, GPER-1: its mechanism of action and role in female reproductive cancer, renal and vascular physiology. Endocrinology 2012, 153:2953-2962.
27. Filice E., Recchia A.G., Pellegrino D., Angelone T., Maggiolini M., Cerra M.C. A new membrane G protein-coupled receptor (GPR30) is involved in the cardiac effects of 17beta-estradiol in the male rat. J. Physiol. Pharmacol. 2009, 60:3-10.
28. Funasaka T., Wong R.W. The role of nuclear pore complex in tumor microenvironment and metastasis. Cancer Metast. Rev. 2011, 30:239-251.
29. Gobeil F., Fortier A., Zhu T., Bossolasco M., Leduc M., Grandbois M., Heveker N., Bkaily G., Chemtob S., Barbaz D. G-protein-coupled receptors signalling at the cell nucleus: an emerging paradigm. Can. J. Physiol. Pharmacol. 2006, 84:287-297.
30. Iyer V.R., Eisen M.B., Ross D.T., Schuler G., Moore T., Lee J.C., Trent J.M., Staudt L.M., Hudson J., Boguski M.S., Lashkari D., Shalon D., Botstein D., Brown P.O. The transcriptional program in the response of human fibroblasts to serum. Science 1999, 283:83-87.
31. Kalluri R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat. Rev. Cancer 2003, 3:422-433.
32. Kalluri R., Zeisberg M. Fibroblasts in cancer. Nat. Rev. Cancer 2006, 6:392-401.
33. Kenny P.A., Bissell M.J. Tumor reversion: correction of malignant behavior by microenvironmental cues. Int. J. Cancer 2003, 107:688-695.
34. Koos R.D. Minireview: putting physiology back into estrogens' mechanism of action. Endocrinology 2011, 152:4481-4488.
35. Lafkas D., Trimis G., Papavassiliou A.G., Kiaris H. P53 mutations in stromal fibroblasts sensitize tumors against chemotherapy. Int. J. Cancer 2008, 123:967-971.
36. Lange A., Mills R.E., Lange C.J., Stewart M., Devine S.E., Corbett A.H. Classical nuclear localization signals: definition, function, and interaction with importin α. J. Biol. Chem. 2007, 282:5101-5105.
37. Lappano R., Maggiolini M. GPCRs and cancer. Acta Pharmacol. Sin. 2012, 33:351-362.
38. Lappano R., Maggiolini M. G protein-coupled receptors: novel targets for drug discovery in cancer. Nat. Rev. Drug Discov. 2011, 10:47-60.
39. Lappano R., Rosano C., De Marco P., De Francesco E.M., Pezzi V., Maggiolini M. Estriol acts as a GPR30 antagonist in estrogen receptor-negative breast cancer cells. Mol. Cell. Endocrinol. 2010, 320:162-170.
40. Lappano R., Rosano C., Santolla M.F., Pupo M., De Francesco E.M., De Marco P., Ponassi M., Spallarossa A., Ranise A., Maggiolini M. Two novel GPER agonists induce gene expression changes and growth effects in cancer cells. Curr. Cancer Drug Targets 2012, 12:531-542.
41. Lappano R., Santolla M.F., Pupo M., Sinicropi M.S., Caruso A., Rosano C., Maggiolini M. MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells. Breast Cancer Res. 2012, 14:R12.
42. Lee D.K., Lança A.J., Cheng R., Nguyen T., Ji X.D., Gobeil F., Chemtob S., George S.R., O'Dowd B.F. Agonist-independent nuclear localization of the Apelin, angiotensin AT1, and bradykinin B2 receptors. J. Biol. Chem. 2004, 279:7901-7908.
43. Liang J., Shang Y. Estrogen and cancer. Annu. Rev. Physiol. 2012, 10.1146/annurev-physiol-030212-183708.
44. Lin B.C., Suzawa M., Blind R.D., Tobias S.C., Bulun S.E., Scanlan T.S., Ingraham H.A. Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation. Cancer Res. 2009, 69:5415-5423.
45. Lin S.Y., Makino K., Xia W., Matin A., Wen Y., Kwong K.Y., Bourguignon L., Hung M.C. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat. Cell Biol. 2001, 9:802-808.
46. Lo H.W., Hsu S.C., Ali-Seyed M., Gunduz M., Xia W., Wei Y., Bartholomeusz G., Shih J.Y., Hung M.C. Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell 2005, 7:575-589.
47. Lohela M., Bry M., Tammela T., Alitalo K. VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr. Opin. Cell Biol. 2009, 21:154-165.
48. Lorusso G., Ruegg C. The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochem. Cell Biol. 2008, 130:1091-1103.
49. Madeo A., Maggiolini M. Nuclear alternate estrogen receptor GPR30 mediates 17β-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts. Cancer Res. 2010, 70:6036-6046.
50. Madeo A., Vinciguerra M., Lappano R., Galgani M., Gasperi-Campani A., Maggiolini M., Musti A.M. C-Jun activation is required for 4-hydroxytamoxifen-induced cell death in breast cancer cells. Oncogene 2010, 29:978-991.
51. Maggiolini M., Donzé O., Picard D. A non-radioactive method for inexpensive quantitative RT-PCR. Biol. Chem. 1999, 380:695-697.
52. Maggiolini M., Picard D. The unfolding stories of GPR30, a new membrane bound estrogen receptor. J. Endocrinol. 2009, 204:105-114.
53. Maggiolini M., Recchia A.G., Carpino A., Vivacqua A., Fasanella G., Rago V., Pezzi V., Briand P.A., Picard D., Andò S. Oestrogen receptor beta is required for androgen-stimulated proliferation of LNCaP prostate cancer cells. J. Mol. Endocrinol. 2004, 32:777-791.
54. Maggiolini M., Vivacqua A., Fasanella G., Recchia A.G., Sisci D., Pezzi V., Montanaro D., Musti A.M., Picard D., Andò S. The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17β-estradiol and phytoestrogens in breast cancer cells. J. Biol. Chem. 2004, 279:27009-27016.
55. Mao Y., Keller E.T., Garfield D.H., Shen K., Wang J. Stromal cells in tumor microenvironment and breast cancer. Cancer Metast. Rev. 2012, 10.1007/s10555-012-9415-3.
56. Marrache A.M., Gobeil F., Zhu T., Chemtob S. Intracellular signaling of lipid mediators via cognate nuclear G protein-coupled receptors. Endothelium 2005, 12:63-72.
57. Matsuda K., Sakamoto H., Mori H., Hosokawa K., Kawamura A., Itose M., Nishi M., Prossnitz E.R., Kawata M. Expression and intracellular distribution of the G protein-coupled receptor 30 in rat hippocampal formation. Neurosci. Lett. 2008, 441:94-99.
58. Miyamoto H., Murakami T., Tsuchida K., Sugino H., Miyake H., Tashiro S. Tumor-stroma interaction of human pancreatic cancer: acquired resistance to anticancer drugs and proliferation regulation is dependent on extracellular matrix proteins. Pancreas 2004, 28:38-44.
59. Morelli C., Garofalo C., Sisci D., del Rincon S., Cascio S., Tu X., Vecchione A., Sauter E.R., Miller W.H., Surmacz E. Nuclear insulin receptor substrate 1 interacts with estrogen receptor alpha at ERE promoters. Oncogene 2004, 23:7517-7526.
60. Müller-Hübenthal B., Azemar M., Lorenzen D., Huber M., Freudenberg M.A., Galanos C., Unger C., Hildenbrand B. Tumour biology: tumour-associated inflammation versus antitumor immunity. Anticancer Res. 2009, 29:4795-4805.
61. Orimo A., Gupta P.B., Sgroi D.C., Arenzana-Seisdedos F., Delaunay T., Naeem R., Carey V.J., Richardson A.L., Weinberg R.A. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121:335-348.
62. Ostman A., Augsten M. Cancer-associated fibroblasts and tumor growth-bystanders turning into key players. Curr. Opin. Genet. Dev. 2009, 19:67-73.
63. Otto C., Rohde-Schulz B., Schwarz G., Fuchs I., Klewer M., Brittain D., Langer G., Bader B., Prelle K., Nubbemeyer R., Fritzemeier K.H. G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol. Endocrinology 2008, 149:4846-4856.
64. Pandey D.P., Lappano R., Albanito L., Madeo A., Maggiolini M., Picard D. Estrogenic GPR30 signaling induces proliferation and migration of breast cancer cells through CTGF. EMBO J. 2009, 28:523-532.
65. Pang Y., Dong J., Thomas P. Estrogen signaling characteristics of Atlantic croaker G protein-coupled receptor 30 (GPR30) and evidence it is involved in maintenance of oocyte meiotic arrest. Endocrinology 2008, 149:3410-3426.
66. Panno M.L., Salerno M., Pezzi V., Sisci D., Maggiolini M., Mauro L., Morrone E.G., Andò S. Effect of oestradiol and insulin on the proliferative pattern and on oestrogen and progesterone receptor contents in MCF-7 cells. J. Cancer Res. Clin. Oncol. 1996, 122:745-749.
67. Prossnitz E.R., Maggiolini M. Mechanisms of estrogen signaling and gene expression via GPR30. Mol. Cell. Endocrinol. 2009, 308:32-38.
68. Pupo M., Pisano A., Lappano R., Santolla M.F., De Francesco E.M., Abonante S., Rosano C., Maggiolini M. Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts. Environ. Health Perspect. 2012, 120:1177-1182.
69. Rago V., Romeo F., Giordano F., Maggiolini M., Carpino A. Identification of the estrogen receptor GPER in neoplastic and non-neoplastic human testes. Reprod. Biol. Endocrinol. 2011, 9:135.
70. Recchia A.G., De Francesco E.M., Vivacqua A., Sisc i D., Panno M.L., Andò S., Maggiolini M. The G protein-coupled receptor 30 is up-regulated by hypoxia-inducible factor-1alpha (HIF-1alpha) in breast cancer cells and cardiomyocytes. J. Biol. Chem. 2011, 286:10773-10782.
71. Revankar C.M., Cimino D.F., Sklar L.A., Arterburn J.B., Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005, 307:1625-1630.
72. Revankar C.M., Mitchell H.D., Field A.S., Burai R., Corona C., Ramesh C., Sklar L.A., Arterburn J.B., Prossnitz E.R. Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30. ACS Chem. Biol. 2007, 2:536-544.
73. Rosano C., Lappano R., Santolla M.F., Ponassi M., Donadini A., Maggiolini M. Recent advances in the rationale design of GPER ligands. Curr. Med. Chem. 2012, 19:6199-6206. (8).
74. Sakamoto H., Matsuda K., Hosokawa K., Nishi M., Morris J.F., Prossnitz E.R., Kawata M. Expression of G protein-coupled receptor-30, a G protein-coupled membrane estrogen receptor, in oxytocin neurons of the rat paraventricular and supraoptic nuclei. Endocrinology 2007, 148:5842-5850.
75. Santolla M.F., Lappano R., De Marco P., Pupo M., Vivacqua A., Sisci D., Abonante S., Iacopetta D., Cappello A.R., Dolce V., Maggiolini M. GPER mediates the up-regulation of fatty acid synthase (FASN) induced by 17β-estradiol in cancer cells and cancer-associated fibroblasts (CAFs). J. Biol. Chem. 2012, 287:43234-43245.
76. Sirianni R., Chimento A., Ruggiero C., De Luca A., Lappano R., Andò S., Maggiolini M., Pezzi V. The novel estrogen receptor, G protein-coupled receptor 30, mediates the proliferative effects induced by 17beta-estradiol on mouse spermatogonial GC-1 cell line. Endocrinology 2008, 149:5043-5051.
77. Smith H.O., Arias-Pulido H., Kuo D.Y., Howard T., Qualls C.R., Lee S.J., Verschraegen C.F., Hathaway H.J., Joste N.E., Prossnitz E.R. GPR30 predicts poor survival for ovarian cancer. Gynecol. Oncol. 2009, 114:465-471.
78. Smith H.O., Leslie K.K., Singh M., Qualls C.R., Revankar C.M., Joste N.E., Prossnitz E.R. GPR30: a novel indicator of poor survival for endometrial carcinoma. Am. J. Obstet. Gynecol. 2007, 196:386.e1-386.e9.
79. Suh E.K., Gumbiner B.M. Translocation of beta-catenin into the nucleus independent of interactions with FG-rich nucleoporins. Exp. Cell Res. 2003, 290:447-456.
80. Thomas P., Pang Y., Filardo E.J., Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005, 146:624-632.
81. Tlsty T.D., Hein P.W. Know thy neighbor: stromal cells can contribute oncogenic signals. Curr. Opin. Genet. Dev. 2001, 11:54-59.
82. Vivacqua A., Bonofiglio D., Albanito L., Madeo A., Rago V., Carpino A., Musti A.M., Picard D., Andò S., Maggiolini M. 17β-Estradiol, genistein and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein-coupled receptor GPR30. Mol. Pharmacol. 2006, 70:1414-1423.
83. Vivacqua A., Bonofiglio D., Recchia A.G., Musti A.M., Picard D., Andò S., Maggiolini M. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17β-estradiol and hydroxytamoxifen in endometrial cancer cells. Mol. Endocrinol. 2006, 20:631-646.
84. Vivacqua A., Lappano R., De Marco P., Sisci D., Aquila S., De Amicis F., Fuqua S.A., Andò S., Maggiolini M. G protein-coupled receptor 30 expression is up-regulated by EGF and TGFα in estrogen receptor α positive cancer cells. Mol. Endocrinol. 2009, 23:1815-1826.
85. Vivacqua A., Romeo E., De Marco P., De Francesco E.M., Abonante S., Maggiolini M. GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells. Breast Cancer Res. Treat. 2012, 133:1025-1035.
86. Wang C., Prossnitz E.R., Roy S.K. G protein-coupled receptor 30 expression is required for estrogen stimulation of primordial follicle formation in the hamster ovary. Endocrinology 2008, 149:4452-4461.
87. Wang Y.N., Yamaguchi H., Hsu J.M., Hung M.C. Nuclear trafficking of the epidermal growth factor receptor family membrane proteins. Oncogene 2010, 29:3997-4006.
88. Watson P.H., Fraher L.J., Natale B.V., Kisiel M., Hendy G.N., Hodsman A.B. Nuclear localization of the type 1 parathyroid hormone/parathyroid hormone-related peptide receptor in MC3T3-E1 cells: association with serum-induced cell proliferation. Bone 2000, 26:221-225.
89. Willard F.S., Crouch M.F. Nuclear and cytoskeletal translocation and localization of heterotrimeric G-proteins. Immunol. Cell Biol. 2000, 78:387-394.
90. Xing F., Saidou J., Watabe K. Cancer associated fibroblasts (CAFs) in tumor microenvironment. Front Biosci. 2010, 15:166-179.
91. Yamaguchi Y., Hayashi S. Estrogen-related cancer microenvironment of breast carcinoma. Endocr. J. 2009, 56:1-7.